SCHEMBL1754893

SCHEMBL1754893

CC(N(c1ccc2ncccc2c1)S(=O)(=O)c1cc(Cl)cc(Cl)c1)P(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
DOT1L Q8TEK3 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLK1 P53350 1/20 0.37
RAPGEF3 O95398 1/20 0.36
NAMPT P43490 1/20 0.36
BCAT1 P54687 1/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
HTR6 P50406 1/20 0.35
PABPC1 P11940 1/20 0.35
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1754860 0.88 ALDH1A1 (0.35) MMP2MMP13NPC1RAB9AHTT
SCHEMBL3277899 0.86 KDR (0.40) MMP2MMP13NPC1RAB9AALDH1A1
SCHEMBL3278252 0.81 SLC40A1 (0.40) HTTALDH1A1LMNASMN1; SMN2POLB
SCHEMBL2055488 0.81 NPC1 (0.39) MMP2MMP13DOT1LNPC1RAB9A
SCHEMBL1754852 0.80 NR3C1 (0.41) NPC1MEN1MAPTKMT2AHTR6
SCHEMBL1754892 0.79 MMP2 (0.39) MMP2MMP13DOT1LNPC1RAB9A
SCHEMBL2099401 0.76 DOT1L (0.38) MMP2MMP13DOT1LNPC1RAB9A
SCHEMBL2055379 0.74 DOT1L (0.38) MMP2MMP13DOT1LNPC1RAB9A
SCHEMBL1753943 0.73 NR4A2 (0.41) MMP2MMP13NPC1RAB9AHTT
SCHEMBL2099819 0.73 MMP2 (0.37) MMP2MMP13DOT1LNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200987-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2010-06-30 EP claimed
WO-2009030715-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-12 WO claimed
EP-2200987-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2010-06-30 EP disclosed
WO-2009030715-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-12 WO disclosed